TLDR
- Piper Sandler initiated coverage on Rocket Lab (RKLB) with a Neutral rating and an $83 price target
- The stock is trading around $66–$76, down sharply, and is flagged as overvalued relative to Fair Value
- CEO Peter Beck sold 1.3 million shares on July 7 at $84.92 under a pre-arranged 10b5-1 plan
- Revenue for the latest quarter was up 63.4% year over year to $200.35 million, beating estimates
- Morgan Stanley holds an Overweight rating with a $105 price target; consensus sits at $110.18
Rocket Lab (RKLB) is having a rough week. The stock dropped roughly 13% and is now trading around $66, well below its 12-month high of $151.
Piper Sandler kicked off coverage Wednesday with a Neutral rating and an $83 price target. The firm based that target on 39 times fiscal year 2027 enterprise value to revenue.
Rocket Lab’s current market cap sits at around $41.5–$44 billion. InvestingPro flags the stock as overvalued relative to its Fair Value, with a Price/Book ratio of 18.88.
The stock trades at a premium to SpaceX on an enterprise value to revenue basis. Piper Sandler expects that valuation relationship to hold over the coming year.
Despite the premium, RKLB has delivered a 59.78% return over the past 12 months and grown revenue 45.83% over the same period. That’s a business moving fast.
Strong Financials, But Questions Remain
The most recent quarterly results were solid. Revenue came in at $200.35 million for Q1, up 63.4% year over year and above the analyst estimate of $189.65 million.
EPS came in at -$0.07, matching consensus. Analysts expect full-year EPS of -$0.26.
The company completed a full-duration Neutron engine test, a key step before the larger rocket’s first launch. That milestone was well received.
Rocket Lab also recently closed an $8 billion deal to acquire Iridium Communications. Morgan Stanley reiterated its Overweight rating following that news, with a $105 price target.
Cantor Fitzgerald also kept its Overweight rating after the successful U.S. Space Force VICTUS HAZE mission, setting a price target of $96.
CEO Share Sales Raise Eyebrows
CEO Peter Beck sold 1,298,622 shares on July 7 at an average price of $84.92, totaling over $110 million. The transaction was made under a pre-arranged Rule 10b5-1 plan.
Beck still holds 2,715,181 shares valued at roughly $230 million after the sale.
In total, insiders have sold 3,849,294 shares worth approximately $362.8 million over the past three months. All trades were made under 10b5-1 plans.
Calamos Advisors also cut its RKLB position by 90.1% in Q1, trimming from 245,980 to 24,393 shares worth about $1.57 million.
Institutional investors still own 71.78% of the stock.
The stock’s 50-day moving average is $108.95 and its 200-day moving average is $87.31. RKLB is trading well below both levels.
The analyst consensus rating is Moderate Buy with an average price target of $110.18. Wells Fargo has the most conservative target at $60, while New Street Research has a Buy with a $150 target.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







